Table 1. Baseline scores (mean ± SD) on the ASQoL, BASDAI, and BASFI based on the presence (+) or absence (–) of SpA features
| ASQoL | BASDAI | BASFI | |||||||
|---|---|---|---|---|---|---|---|---|---|
| + | – | P | + | – | P | + | – | P | |
| Peripheral Arthritis | 10.4±4.6 | 9.1±5.0 | <0.0001 | 5.1±1.9 | 4.3±2.0 | <0.0001 | 3.5±2.2 | 3.0±2.3 | <0.0001 |
| Enthesitis | 10.5±4.8 | 8.0±4.8 | <0.0001 | 4.9±1.9 | 4.0±2.0 | <0.0001 | 3.5±2.3 | 2.6±2.2 | <0.0001 |
| Uveitis | 8.4±5.0 | 9.3±5.0 | <0.0001 | 4.3±2.1 | 4.5±2.0 | <0.0001 | 2.4±2.1 | 3.1±2.3 | <0.0001 |
| Psoriasis | 10.0±4.9 | 9.1±5.0 | <0.0001 | 4.8±2.0 | 4.4±2.0 | <0.0001 | 3.6±2.3 | 3.0±2.3 | <0.0001 |
| Anterior Chest Wall Pain | 10.1±4.7 | 8.6±5.1 | <0.0001 | 4.8±2.0 | 4.3±2.0 | <0.0001 | 3.4±2.3 | 2.8±2.2 | <0.0001 |
| IBD | 9.6±5.2 | 9.2±5.0 | <0.0001 | 4.4±2.0 | 4.5±2.0 | <0.0001 | 3.3±2.3 | 3.0±2.3 | <0.0001 |